Bioinformatics Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2023-2030 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

Bioinformatics Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2023-2030 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

The global bioinformatics market has witnessed significant growth over the past decade as it bridges the gap between biological information and technology for efficient data storage, analysis, and distribution across healthcare centers. Bioinformatics employs software applications for systematic data management, warehousing, mining, and database creation, playing a crucial role in biomedicine development. The COVID-19 pandemic further accelerated the adoption of bioinformatics, given its ability to store and manage vast volumes of data.

Emerging Opportunities in Bioinformatics Market

The pressing need for integrated data solutions, nucleic acid and protein sequencing, as well as the integration of artificial intelligence (AI) and machine learning in healthcare, is expected to drive the growth of the bioinformatics market in the coming years. Government and private organizations are making significant investments in drug discovery and development, providing lucrative growth opportunities. Moreover, the reduction in the cost of sequencing and the increased number of proteomics & genomics applications are set to propel the demand for bioinformatics during the forecasted period.

Research and Development Boosting Bioinformatics

As the healthcare industry rapidly embraces bioinformatics, key players in the sector are intensifying their research and development activities. Technological advancements are imperative for the evolution of bioinformatics applications, which are now applicable across diverse fields of biological sciences. In the forecasted period, the enhancement and evolution of bioinformatics capabilities will remain a focal point for leading players in the bioinformatics market. Proliferating research and development activities, growing demand for bioinformatics experts to support increasing biotechnology activities, and the rising demand for tools used for DNA sequencing and genotyping will be constant growth drivers.

North America Dominates, Asia Pacific Shows Promise

North America is expected to experience extensive growth in the bioinformatics market over the forecasted period. The rapid adoption of medical informatics by healthcare establishments and real-time availability of patient information are driving the demand for bioinformatics in the region. Additionally, automation is enhancing efficiency and eliminating errors in various operations such as hospital inventory management, medication dispensing, and ordering supplies, further fueling the demand for bioinformatics in North America.

Asia Pacific is poised to be among the largest regional markets for bioinformatics. Economies like China, Australia, and Japan are witnessing significant scientific research and development activities, fueled by strategic government investments in the healthcare sector. This growth is attributed to the allocation of funds towards healthcare, creating opportunities for players to develop bioinformatics software applications to cater to the growing demand in the APAC region. Furthermore, the increased funding in healthcare has opened new avenues for hospitals, diagnostic centers, and pharmaceutical companies, driving the demand for bioinformatics software applications in the region.

Prominent Players in the Bioinformatics Market

Several prominent players are operating in the global bioinformatics market, including Thermo Fisher Scientific, Biomax Informatics AG (Germany), Fios Genomics (UK), Source BioScience (UK), Agilent Technologies, Inc. (US), Eurofins Scientific (Luxembourg), Illumina, Inc. (US), NeoGenomics Laboratories (US), Perkin Elmer, Inc. (US), Waters Corporation (US), DNASTAR (US), SOPHiA Genetics (Switzerland), QIAGEN N.V. (Netherlands), BGI Group (China), Partek Incorporated (US), and GENEWIZ (US).

Please Note: It will take 5 business days to complete the report upon order confirmation.

Please note: The PDF e-mail from publisher version of this report is for a global site license.